Skip to main content

Table 2 The clinical characteristics of all MDS patients

From: Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes

Characteristics Values
Tested patients (n) 82
Median age (range) 58 (21–83)
 Sex, n (%)
  Male 42 (51)
  Female 40 (49)
 WHO 2016 classification, n (%)
  MDS-SLD 8 10)
  MDS-RS 4 (5)
  MDS-MLD 40 (49)
  MDS-EB-1 17 (20)
  MDS-EB-2 13 (16)
 IPSS risk groups, n (%)
  Low 5 (6)
  Intermediate-1 54 (66)
  Lower-risk 59 (72)
  Intermediate-2 20 (24)
  High 3 (4)
  Higher-risk 23 (28)
 Karyotypes by IPSS, n (%)
  Good 54 (66)
  Intermediate 15 (18)
  Poor 13 (16)
  1. WHO World Health Organization, MDS myelodysplastic syndrome, SLD single lineage dysplasia, RS ring sideroblasts, MLD multilineage dysplasia, EB excess of blasts, IPSS International Prognostic Scoring System